NAMS

Market Recap Check: NewAmsterdam Pharma Company NV (NAMS)’s Positive Finish at 34.02, Up/Down 1.61
Kiel Thompson
Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be ...

Stock Surge: NewAmsterdam Pharma Company NV (NAMS) Closes at $33.68, Marking a -1.58 Increase/Decrease
Abby Carey
The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for ...

Ratio Revelations: NewAmsterdam Pharma Company NV (NAMS)’s Financial Metrics in the Spotlight
Abby Carey
Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental ...

Market Resilience: NewAmsterdam Pharma Company NV (NAMS) Finishes Weak at 35.52, Down -7.33
Ulysses Smith
The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for ...



